Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10.
Mol Ther Oncolytics. 2022 Mar 16;25:43-56. doi: 10.1016/j.omto.2022.03.007. eCollection 2022 Jun 16.
Mol Ther Oncolytics. 2022.
PMID: 35399606
Free PMC article.
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20.
Davies JA, Marlow G, Uusi-Kerttula HK, Seaton G, Piggott L, Badder LM, Clarkson RWE, Chester JD, Parker AL.
Davies JA, et al. Among authors: uusi kerttula hk.
Viruses. 2021 May 8;13(5):864. doi: 10.3390/v13050864.
Viruses. 2021.
PMID: 34066836
Free PMC article.
Item in Clipboard
Cite
Cite